| 101 |
Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release |
Dalma Martinovic-Weigelt |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
2 AOs
|
|
|
| 102 |
Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition |
Dalma Martinovic-Weigelt |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
2 AOs
|
|
|
| 103 |
Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint |
Dalma Martinovic-Weigelt |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
2 AOs
|
|
|
| 104 |
Altered ion channel activity leading impaired heart function |
Undefined |
BY-SA |
697: impaired, ion channels
|
351: Increased Mortality
|
|
|
| 105 |
Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat) |
Charles Wood |
BY-SA |
714: Increased, Binding of chemicals to 2u (serum)
|
713: Increase, Adenomas/carcinomas (renal tubular)
|
|
|
| 108 |
Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat) |
Charles Wood |
BY-SA |
724: Inhibition, Pyruvate dehydrogenase kinase (PDK) enzyme
|
719: Increase, hepatocellular adenomas and carcinomas
|
|
|
| 71 |
Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation |
Undefined |
BY-SA |
650: Stimulation of adult Leydig cells via the Adrenal Corticosterone, Increased Glucocorticoid
|
520: Decreased sperm quantity or quality in the adult, Decreased fertility
|
|
|
| 4 |
Ecdysone receptor agonism leading to mortality via suppression of Ftz-f1 |
Knut Erik Tollefsen |
BY-SA |
103: Increase, Ecdysone receptor hyperactivation
|
2 AOs
|
|
|
| 19 |
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) |
Mukesh Patel |
Open for adoption |
26: Antagonism, Androgen receptor
|
337: N/A, Impairment of reproductive capacity
|
|
|
| 26 |
Calcium-mediated neuronal ROS production and energy imbalance |
Lyle Burgoon |
Open for adoption |
51: Inhibition, Ca++ ATPase
|
1392: Increase, Oxidative Stress
|
|
|
| 28 |
Cyclooxygenase inhibition leading reproductive failure |
Dan Villeneuve |
BY-SA |
79: Inhibition, Cyclooxygenase activity
|
253: N/A, Reproductive failure
|
|
|
| 29 |
Estrogen receptor agonism leading to reproductive dysfunction |
Undefined |
BY-SA |
111: Agonism, Estrogen receptor
|
4 AOs
|
|
|
| 32 |
Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors |
Undefined |
BY-SA |
None
|
None
|
|
|
| 33 |
Kidney toxicity induced by activation of 5HT2C |
Kevin Crofton |
Open for adoption |
9: Activation, 5HT2c
|
759: Increased, Kidney Failure
|
|
|
| 34 |
LXR activation leading to hepatic steatosis |
Undefined |
BY-SA |
2 MIEs
|
345: N/A, Liver Steatosis
|
|
|
| 36 |
Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis |
Michelle Angrish |
BY-SA |
3 MIEs
|
459: Increase, Liver steatosis
|
|
|
| 52 |
ER agonism leading to skewed sex ratios due to altered sexual differentiation in males |
Undefined |
BY-SA |
111: Agonism, Estrogen receptor
|
417: skewed, sex ratio
|
|
|
| 53 |
ER agonism leading to reduced survival due to renal failure |
Undefined |
BY-SA |
111: Agonism, Estrogen receptor
|
None
|
|
|
| 57 |
AhR activation leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
18: Activation, AhR
|
459: Increase, Liver steatosis
|
|
|
| 59 |
HNF4alpha suppression leading to hepatic steatosis |
Michelle Angrish |
BY-SA |
461: Suppression, HNF4alpha
|
None
|
|
|
| 70 |
Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell |
Undefined |
BY-SA |
640: Decreased steroidogenesis, Proteomic alterations in the adult Leydig cell
|
520: Decreased sperm quantity or quality in the adult, Decreased fertility
|
|
|
| 69 |
Modulation of Adult Leydig Cell Function Subsequent to Decreased Cholesterol Synthesis or Transport in the Adult Leydig Cell |
Undefined |
BY-SA |
3 MIEs
|
646: Decreased Cholesterol, Decreased sperm quantity and/or quality in the adult testis
|
|
|
| 68 |
Modulation of Adult Leydig Cell Function Subsequent to Alterations in the Fetal Testis Protome |
Undefined |
BY-SA |
661: Decreased testosterone by the fetal Leydig cells, Alterations in the fetal testis proteome
|
505: Decreased sperm quantity / quality in the adult, Decreased fertility
|
|
|
| 67 |
Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis |
Undefined |
BY-SA |
2 MIEs
|
505: Decreased sperm quantity / quality in the adult, Decreased fertility
|
|
|
| 66 |
Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis |
Undefined |
BY-SA |
2 MIEs
|
505: Decreased sperm quantity / quality in the adult, Decreased fertility
|
|
|